(CIDRAP News) – Some professional groups and scientists think it's a good idea to classify highly pathogenic avian (HPAI) H5N1 influenza viruses as "select agents" requiring special research precautions, while others say the step is unnecessary and would impede research, according to comments they have filed with the US Department of Health and Human Services (HHS).
Editor's Note: This is the first of a series of articles reviewing the world's experience with pandemic H1N1 influenza and what we've learned in the past year. Look for further installments in the days to come.
(CIDRAP News) A year's experience with the 2009 H1N1 influenza virus has underscored the endless unpredictability of flu.
(CIDRAP News) – At an Infectious Diseases Society of America (IDSA) symposium in Washington, DC, today on seasonal and pandemic influenza, a group of experts fielded questions from reporters on some of the new trends and emerging issues, including prepandemic strategies for H5N1 avian influenza vaccines, now that some countries are stockpiling them.
WASHINGTON, DC (CIDRAP News) Health officials worldwide are becoming increasingly concerned about influenza viruses' resistance to antiviral drugs, which can shut down a flu infection or mitigate symptoms. Flu antivirals are vital for reducing severe illness and death in average flu seasons and could be essential bulwarks against an influenza pandemic if one began.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
(CIDRAP News) – The Bush administration's new budget proposes adding funds for pandemic preparedness while cutting some support for bioterrorism and local preparedness, drawing mixed reviews from national public health groups.
(CIDRAP News) New federal recommendations on nonpharmaceutical measures communities can use to fight an influenza pandemic are drawing generally high marks from public health officials and others, but they say the plan spells a massive workload for local planners.